METTL14 and neoplasm: Recently, C1Q+ TAMs have been reported to influence CD8+ T cell enrichment in tumors and Mettl14 or Ythdf2 deficiency in TAMs impedes tumor eradication by reducing cytotoxic T cell infiltration and encourage the accumulation of defective CD8+ T cells [47].